PSMD1 and infection: An analysis from the linear mixed model identified COVID-19 infection history, age groups and breakthrough infection as having significant effects (p < 0.001) on the kinetics of anti-S1-RBD antibody titre over time, BMI category and comorbidities only showed a marginal effect on antibody titre (Table 2 and Supplementary Table 1).